Tag: Biotechnology
March 16, 2020
Intellectual Property | Patent
Intellectual Property | Patent
Valid claiming of priority rights in patent application...
On 16 January 2020, the European Patent Office (EPO) Board of Appeal revoked a patent related to CRISPR/Cas9 technology, and in doing so delivered one of the most anticipated decisions in the field of biotechnology patents in recent times. This gene-editing technology, which is the subject of a bitter battle for intellectual property rights between two rival parties - The Broad Institute and the University of California (UC), Berkeley, is revolutionizing research in biotechnology....
October 22, 2018
Intellectual Property | Patent
Intellectual Property | Patent
Usefulness and claim construction of nucleic acid seque...
Essenese Obhan, Managing Partner at Obhan & Associates, explores the two clauses that clarify how a nucleic acid sequence, without indication of a function, does not contain any technical information and is not a patentable invention. The key requirement of patentability is that the invention must be ‘capable of industrial application’; claim construction must be based on it being non-obvious and useful. These are the aspects studied to understand why nucleic acid sequences don’t fall in the the patentable category....